mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.6 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.15 |
0.6 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Obatoclax Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.6 |